Davita Healthcare Partners, Inc. (NYSE:DVA)
CAPS Rating:
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
Recs
Fraud allegations and trial -- bad publicity and potential for increased federal scrutiy.